- Conditions
- Adenocarcinoma, Adnexal Diseases, Amyloidosis, +130 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
Clinical trial condition
Hodgkin Disease
Explore clinical trials studying Hodgkin Disease. Study availability and eligibility vary by location and protocol.
958 public trials
99 recruiting studies
Hodgkin Disease trial results
NCT01676805
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +23 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of the West Indies Kingston, Jamaica
Recruiting
Personalized NK Cell Therapy in CBT
NCT02727803
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT02682667
- Conditions
- Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +31 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT07020533
- Conditions
- Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Northside Hospital Atlanta, Georgia, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT06150664
- Conditions
- Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +37 more
- Locations
-
- D&H Cancer Research Center Margate, Florida, United States
- Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
- Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
- University Cancer & Blood Center Athens, Georgia, United States
Recruiting
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
NCT06176690
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type, +17 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
Recruiting
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
NCT03618550
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
- Locations
-
- City of Hope Cancer Center (Data Collection Only) Duarte, California, United States
- Stanford University Medical Center Stanford, California, United States
- University of Miami Miami, Florida, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
Recruiting
Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas
NCT04288726
- Conditions
- Classical Hodgkin Lymphoma, Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Houston Methodist Hospital Houston, Texas, United States
- Texas Children's Hospital Houston, Texas, United States
NCT06580002
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Brain Cancer, +104 more
- Locations
-
- Chao Family Comprehensive Cancer Center, University of California Irvine Orange, California, United States